BioMarin也迅速跟进迭代研发，其升级版在研产品BMN333同样旨在实现周剂注射。早期临床结果显示BMN333的AUC水平高于其他长效CNP研究的3倍以上，公司研发主管Greg Friberg表示该药对标的正是TransCon-CNP。
A leading campaigner has accused the prime minister of "appeasing" big tech companies and being "late to the party" in regulating social media and artificial intelligence.
，这一点在爱思助手下载最新版本中也有详细论述
Марина Совина (ночной редактор)
Marc Prud’hommeaux
for (let i = 0; i < n; i++) {